ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B02BX06 | BioTech | Emicizumab - 105mg/0.7ml | 9905/945 | 102018/1 | HEMLIBRA | 105mg/0.7ml | 1x0.7ml | Injectable solution | SC | Omnipharma | Chugai Pharma Manufacturing Co Ltd | Japan | 577,741,643 L.L | 2.44 | E2 | F. Hoffmann La Roche Ltd | Switzerland | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B02BX06 | BioTech | Emicizumab - 105mg/0.7ml | 9905 | 102018/1 | HEMLIBRA | 105mg/0.7ml | 1x0.7ml | Injectable solution | SC | Omnipharma | Chugai Pharma Manufacturing Co Ltd | Japan | 11,845,462 L.L | 2.44 | E2 | F. Hoffmann La Roche Ltd | Switzerland | 2/5/2024 |